Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307

Gregory L. Krauss, Emilio Perucca, Patrick Kwan, Elinor Ben-Menachem, Xue Feng Wang, Jerry J. Shih, Anna Patten, Haichen Yang, Betsy Williams, Antonio Laurenza

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307'. Together they form a unique fingerprint.

Medicine & Life Sciences